Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;8(2):103-12.

Mimicry and deception in inflammatory bowel disease and intestinal behçet disease

Affiliations

Mimicry and deception in inflammatory bowel disease and intestinal behçet disease

Erika L Grigg et al. Gastroenterol Hepatol (N Y). 2012 Feb.

Abstract

Behçet disease (BD) is a rare, chronic, multisystemic, inflammatory disease characterized by recurrent oral aphthous ulcers, genital ulcers, uveitis, and skin lesions. Intestinal BD occurs in 10-15% of BD patients and shares many clinical characteristics with inflammatory bowel disease (IBD), making differentiation of the 2 diseases very difficult and occasionally impossible. The diagnosis of intestinal BD is based on clinical findings-as there is no pathognomonic laboratory test-and should be considered in patients who present with abdominal pain, diarrhea, weight loss, and rectal bleeding and who are susceptible to intestinal BD. Treatment for intestinal BD is similar to that for IBD, but overall prognosis is worse for intestinal BD. Although intestinal BD is extremely rare in the United States, physicians will increasingly encounter these challenging patients in the future due to increased immigration rates of Asian and Mediterranean populations.

Keywords: Behçet disease; Crohn's disease; Intestinal Behçet disease; inflammatory bowel disease; ulcerative colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proposed classification scheme for differentiating between intestinal Behçet disease and Crohn's disease.
Figure 2
Figure 2
Algorithm for the diagnosis of intestinal Behçet disease (BD). *Subtypes of systemic BD were classified according to the diagnostic criteria of the Research Committee of Japan. **Close follow-up surveillance is necessary.

References

    1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284–1291. - PubMed
    1. Behçet H. Rezidivierende aphthose, durch ein virus verusachte geschwure am auge und an den genitalien. Dermatol Wochenschr. 1937;105:1152–1157.
    1. Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behçet's disease. J Clin Gastroenterol. 2000;30:144–154. - PubMed
    1. Cheon JH, Han DS, Park JY, et al. Korean IBD Study Group Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis. 2011;17:605–613. - PubMed
    1. Moon CM, Cheon JH, Shin JK, et al. Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings. Dig Dis Sci. 2010;55:2904–2911. - PubMed

LinkOut - more resources